FatiAbGen is a leading antibody-based platform company with a broad clinical pipeline for Oncology and Allergy disease treatment using our best-in-class therapeutic antibodies.
FatiAbGen has a strong global view with passion. FatiAbGen is the first Korean company to be a member of Shonan iPark, the largest biotech cluster in Japan.
FatiAbGen became a member of the JLABS family in 2023, strongly aligned with J&J’s innovative portfolio.
In 2024, FatiAbGen established a new subsidiary in Basel Switzerland to accelerate business development for future out-licensing.
Company Details
- Employees
- 7
- Founded
- 2020
- Address
- 집현중앙7로 6, 지식산업센터 A동 514호, 세종특별자치시 / Basel,30141,korea, Republic Of
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.fatiabgen.com
- Keywords
- Oncology, Immunology, Allergy, Antibody-drug conjugates, ADC, bi-specific antibodies, Car-T, mesothelin, solid tumors, MSLN ADC, IgE, Autoimmune.
- HQ
- 세종특별자치시 / Basel
Fatiabgen Inc. Questions
Fatiabgen Inc.'s website is http://www.fatiabgen.com
Fatiabgen Inc.'s LinkedIn profile is https://kr.linkedin.com/company/fatiabgen-inc
Fatiabgen Inc. has
7 employees.
View email and phone details for 7
employees at Fatiabgen Inc..
Fatiabgen Inc.'s industry is
Pharmaceutical Manufacturing
Fatiabgen Inc.'s top competitors are
Jnana Therapeutics,
Quant Biomarkers,
T-Oncology Ag,
Phialogics - The Native Biologics Platform Company,
Sensyne Health,
Gio Therapeutics,
Selmod,
Amporin Pharmaceuticals,
Atopia Therapeutics,
Life Science Innovations Corp.
Fatiabgen Inc.'s categories are Pharmaceutical Manufacturing
Fatiabgen Inc.'s founding year is 2020
